Page 6,662«..1020..6,6616,6626,6636,664..6,6706,680..»

Lazarus Effect Funnelâ„¢ Guide Catheter Receives CE Mark

Posted: Published on July 21st, 2012

- First of four products in development to improve outcomes of ischemic stroke treatment - CAMPBELL, California, July 20, 2012 /PRNewswire/ -- Lazarus Effect, a medical device company focused on improving treatment of acute ischemic stroke through effective removal of the blood clots that cause a stroke, announced today that the Lazarus Funnel Guide Catheterhasreceived CE Mark. The Lazarus Funnel is a unique, single-lumen catheter designed to enhance the introduction and removal of interventional devices, including those used to treat acute ischemic stroke. Lazarus Effect plans to launch the Lazarus Funnel in Europe during Q1 2013. The company is currently evaluating distribution partners. "The Lazarus Funnel offers the potential to reduce the incidence of secondary stroke resulting from clot pieces lost during removal with standard thrombectomy devices, " said Martin Dieck, chairman and CEO, Lazarus Effect. "It is the first in a series of products we are developing to address the limitations of current stroke intervention systems and the challenges posed by the broad range of clot types that cause ischemic stroke." Approximately two million strokes occur in Europe each year. Seventy-eight percent of these are ischemic and caused by a dislodged blood clot or arterial plaque debris traveling to … Continue reading →

Comments Off on Lazarus Effect Funnelâ„¢ Guide Catheter Receives CE Mark

Severe flu increases risk of Parkinson's: UBC research

Posted: Published on July 21st, 2012

Public release date: 20-Jul-2012 [ | E-mail | Share ] Contact: Brian Kladko brian.kladko@ubc.ca 604-827-3301 University of British Columbia Severe influenza doubles the odds that a person will develop Parkinson's disease later in life, according to University of British Columbia researchers. However, the opposite is true for people who contracted a typical case of red measles as children they are 35 per cent less likely to develop Parkinson's, a nervous system disorder marked by slowness of movement, shaking, stiffness, and in the later stages, loss of balance. The findings by researchers at UBC's School of Population and Public Health and the Pacific Parkinson's Research Centre, published online this month in the journal Movement Disorders, are based on interviews with 403 Parkinson's patients and 405 healthy people in British Columbia, Canada. Lead author Anne Harris also examined whether occupational exposure to vibrations such as operating construction equipment had any effect on the risk of Parkinson's. In another study, published online this month by the American Journal of Epidemiology, she and her collaborators reported that occupational exposure actually decreased the risk of developing the disease by 33 percent, compared to people whose jobs involved no exposure. Meanwhile, Harris found that those exposed … Continue reading →

Posted in Parkinson's Treatment | Comments Off on Severe flu increases risk of Parkinson's: UBC research

Parkinson's: Newly discovered antibody could facilitate early diagnosis

Posted: Published on July 21st, 2012

ScienceDaily (July 20, 2012) Conditions such as Parkinson's disease are a result of pathogenic changes to proteins. In the neurodegenerative condition of Parkinson's disease, which is currently incurable, the alpha-synuclein protein changes and becomes pathological. Until now, there have not been any antibodies that could help to demonstrate the change in alpha-synuclein associated with the disease. An international team of experts led by Gabor G. Kovacs from the Clinical Institute of Neurology at the MedUni Vienna has now discovered a new antibody that actually possesses this ability. "It opens up new possibilities for the development of a diagnostic test for Parkinsonism," says Kovacs, highlighting the importance of this discovery. "This new antibody will enable us to find the pathological conformation in bodily fluids such as blood or CSF." A clinical study involving around 200 patients is already underway, and the first definitive results are expected at the end of 2012. The tests being carried out in collaboration with the University Department of Neurology, led by Walter Pirker, are designed to determine the extent to which the new antibody can be used as an early diagnostic tool in order to understand the condition better and be able to treat it more … Continue reading →

Posted in Parkinson's Treatment | Comments Off on Parkinson's: Newly discovered antibody could facilitate early diagnosis

Severe flu increases risk of Parkinson's

Posted: Published on July 21st, 2012

ScienceDaily (July 20, 2012) Severe influenza doubles the odds that a person will develop Parkinson's disease later in life, according to University of British Columbia researchers. However, the opposite is true for people who contracted a typical case of red measles as children -- they are 35 per cent less likely to develop Parkinson's, a nervous system disorder marked by slowness of movement, shaking, stiffness, and in the later stages, loss of balance. The findings by researchers at UBC's School of Population and Public Health and the Pacific Parkinson's Research Centre, published online this month in the journal Movement Disorders, are based on interviews with 403 Parkinson's patients and 405 healthy people in British Columbia, Canada. Lead author Anne Harris also examined whether occupational exposure to vibrations -- such as operating construction equipment -- had any effect on the risk of Parkinson's. In another study, published online this month by the American Journal of Epidemiology, she and her collaborators reported that occupational exposure actually decreased the risk of developing the disease by 33 percent, compared to people whose jobs involved no exposure. Meanwhile, Harris found that those exposed to high-intensity vibrations -- for example, by driving snowmobiles, military tanks or … Continue reading →

Posted in Parkinson's Treatment | Comments Off on Severe flu increases risk of Parkinson's

Popular MS drug may not prevent disability from progressing in patients

Posted: Published on July 21st, 2012

VANCOUVER -- Researchers in Vancouver suggest a widely used treatment for the most common form of multiple sclerosis may not prevent the progression of disability. Multiple sclerosis attacks the brain and spinal cord, and can cause neurological issues which range from mild problems to serious disability, such as paralysis. The drugs which were studied, known as beta interferons, have been used to treat the relapsing-remitting form of MS since 1995. But a new study from the UBC Hospital MS Clinic and Brain Research Centre published in the Journal of the American Medical Association, suggests the drugs arent preventing the progression of disability. However, the researchers warn that the studys results werent meant to suggest that MS patients stop taking the drugs as the medications are still effective at reducing relapse rates. Dr. Helen Tremlett, one of the studys authors, says the finding is just coming to light because in the past, not enough time had elapsed from when the drugs were approved to treat the disease. A total of 2,656 patients with MS were looked at. Of those, 868 were treated with the beta interferon drugs and were compared with both contemporary and historical cases of patients who went untreated. … Continue reading →

Posted in MS Treatment | Comments Off on Popular MS drug may not prevent disability from progressing in patients

Sweat glands grown from newly identified stem cells

Posted: Published on July 21st, 2012

ScienceDaily (July 20, 2012) To date, few fundamentals have been known about the most common gland in the body, the sweat glands that are essential to controlling body temperature, allowing humans to live in the worlds diverse climates. Now, in a tour de force, researchers at The Rockefeller University and the Howard Hughes Medical Institute have identified, in mice, the stem cell from which sweat glands initially develop as well as stem cells that regenerate adult sweat glands. In their study, published in Cell, the scientists devised a strategy to purify and molecularly characterize the different kinds of stem cell populations that make up the complex sweat duct and glands of the skin. With this information in hand, they studied how these different populations of stem cells respond to normal tissue homeostasis and to different types of skin injuries, and how the sweat glands differ from their close cousins, the mammary glands. No sweat. Researchers in Elaine Fuchs's lab identified four different types of paw-skin progenitor cells that are responsible for homeostasis and wound repair. This image shows that the sweat ductal and epidermal progenitors (in red) proliferate and repair an epidermal scratch wound; the sweat gland progenitors (in blue … Continue reading →

Posted in Stem Cell Research | Comments Off on Sweat glands grown from newly identified stem cells

BUSM researchers identify genetic markers for testosterone, estrogen level regulation

Posted: Published on July 21st, 2012

Public release date: 20-Jul-2012 [ | E-mail | Share ] Contact: Jenny Eriksen Leary jenny.eriksen@bmc.org 617-638-6841 Boston University Medical Center (Boston) A research study led by Boston University School of Medicine (BUSM) and the University of Exeter in the United Kingdom, in collaboration with a global consortium, has identified genetic markers that influence a protein involved in regulating estrogen and testosterone levels in the bloodstream. The results, published online in PLoS Genetics, also reveal that some of the genetic markers for this protein are near genes related to liver function, metabolism and type 2 diabetes, demonstrating an important genetic connection between the metabolic and reproductive systems in men and women. Andrea D. Coviello, MD, assistant professor of medicine at BUSM and an endocrinologist at Boston Medical Center, is one of the paper's lead authors. This study was done in collaboration with the Framingham Heart Study and investigators from 15 international epidemiologic studies participating in the Cohorts for Heart and Aging Research in Genetic Epidemiology (CHARGE) consortium. Sex hormone-binding globulin (SHBG) is the key protein that carries testosterone and estrogen in the bloodstream in both men and women. As the main carrier of these sex hormones, SHBG helps to regulate their … Continue reading →

Comments Off on BUSM researchers identify genetic markers for testosterone, estrogen level regulation

Genetic markers for testosterone, estrogen level regulation identified

Posted: Published on July 21st, 2012

ScienceDaily (July 20, 2012) A research study led by Boston University School of Medicine (BUSM) and the University of Exeter in the United Kingdom, in collaboration with a global consortium, has identified genetic markers that influence a protein involved in regulating estrogen and testosterone levels in the bloodstream. The results, published online in PLoS Genetics, also reveal that some of the genetic markers for this protein are near genes related to liver function, metabolism and type 2 diabetes, demonstrating an important genetic connection between the metabolic and reproductive systems in men and women. Andrea D. Coviello, MD, assistant professor of medicine at BUSM and an endocrinologist at Boston Medical Center, is one of the paper's lead authors. This study was done in collaboration with the Framingham Heart Study and investigators from 15 international epidemiologic studies participating in the Cohorts for Heart and Aging Research in Genetic Epidemiology (CHARGE) consortium. Sex hormone-binding globulin (SHBG) is the key protein that carries testosterone and estrogen in the bloodstream in both men and women. As the main carrier of these sex hormones, SHBG helps to regulate their effects in different tissues and organs in the body. In addition to effects on reproduction in men … Continue reading →

Comments Off on Genetic markers for testosterone, estrogen level regulation identified

Genetic markers for testosterone and estrogen level regulation identified

Posted: Published on July 21st, 2012

Public release date: 20-Jul-2012 [ | E-mail | Share ] Contact: Andrew Gould andrew.gould@pcmd.ac.uk 44-188-438-346 The Peninsula College of Medicine and Dentistry A research study led by the Peninsula College of Medicine and Dentistry, University of Exeter, and Boston University School of Medicine, in collaboration with a global consortium, has identified genetic markers that influence a protein involved in regulating oestrogen and testosterone levels in the bloodstream. The results, published online in PLoS Genetics, also reveal that some of the genetic markers for this protein are near genes related to liver function, metabolism and type 2 diabetes, demonstrating an important genetic connection between the metabolic and reproductive systems in men and women. The study was carried out in collaboration with the Framingham Heart Study and investigators from 15 international epidemiologic studies participating in the Cohorts for Heart and Aging Research in Genetic Epidemiology (CHARGE) consortium. Sex hormone binding globulin (SHBG) is the key protein that carries testosterone and oestrogen in the bloodstream in both men and women. As the main carrier of these sex hormones, SHBG helps to regulate their effects in different tissues and organs in the body. In addition to effects on reproduction in men and women through … Continue reading →

Comments Off on Genetic markers for testosterone and estrogen level regulation identified

Can Recreational ED Drug Use Lead to ED?

Posted: Published on July 21st, 2012

Recreational Erectile Dysfunction Drug Use in Young Men May Lead to ED, Study Says July 20, 2012 -- Men who use erectile dysfunction (ED) drugs recreationally may be more likely to develop psychogenic ED, the type that originates in the mind, according to new research. "Recreational use of ED medications increased the chance of psychological dependence on ED medicines,'' says researcher Christopher Harte, PhD, a postdoctoral fellow at the VA Boston Healthcare System. "Among young, healthy men who used ED medicines recreationally, the more frequent ED medicine use was associated with lower confidence in achieving and maintaining erections, which in turn was associated with lower erectile function," Harte says. The study is published in the Journal of Sexual Medicine. The researchers found a link but not cause and effect, Harte tells WebMD. However, another expert wonders if some of the men who reported ''recreational'' use actually had ED. ED affects about 34 million men in the U.S., according to Harte. The condition is more common with age. About 9% of men 18 to 39 are affected. Up to 70% of men 60 and older are. However, men aged 18 to 45 are responsible for the largest increase in the use … Continue reading →

Posted in Erectile Dysfunction | Comments Off on Can Recreational ED Drug Use Lead to ED?

Page 6,662«..1020..6,6616,6626,6636,664..6,6706,680..»